FIELD: medicine, cardiology, endocrinology.
SUBSTANCE: one should calculate coefficient of metabolic dyslipidemia and anthropometric coefficient. At the value of anthropometric coefficient being below 37.9 kg/sq. m and that of metabolic dyslipidemia being above 9.2 c.u. on should predict maximal risk for disease development. The innovation in question enables to increase the accuracy of diagnostics due to detecting the ratio for manifestation of atherogeneity of dyslipidemia and abdominal obesity.
EFFECT: higher efficiency and accuracy of prediction.
4 dwg, 2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF BIOIMPEDANCE DETECTION OF METABOLIC SYNDROME AND TYPE 2 DIABETES MELLITUS PREDICTOR IN YOUNG PEOPLE WITH NORMAL BODY WEIGHT | 2009 |
|
RU2408261C1 |
| METHOD FOR METABOLIC SYNDROM DIAGNOSTICS | 2007 |
|
RU2336807C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPMENT OF INSULIN RESISTANCE | 2019 |
|
RU2748034C2 |
| METHOD FOR PREDICTION OF RISK OF METABOLIC SYNDROME | 2013 |
|
RU2530770C1 |
| METHOD OF SELECTING DRUG THERAPY OF ATHEROGENIC DYSLIPIDEMIA IN CHILDREN AND TEENAGERS WITH ABDOMINAL-VISCERAL OBESITY | 2011 |
|
RU2455931C1 |
| METHOD DETERMINING TACTICS OF CARRYING OUT OF MEDICAL ACTIONS AT PATIENTS WITH METABOLIC SYNDROME AGAINST ARTERIAL HYPERTENSIA | 2007 |
|
RU2337612C1 |
| METHOD FOR INDIVIDUAL PREVENTION OF OESTROGEN-DEPENDENT DISEASES AND REPRODUCTIVE DISORDERS IN FEMALES AT AGE OF 18-35 YEARS OLD SUFFERING METABOLIC DISORDERS | 2013 |
|
RU2527358C1 |
| USE OF RHODANINE DERIVATIVE 3-(2-PHENYLETHYL)-2-THIOXO-1,3 THIAZOLIDIN-4-ONE FOR CORRECTION OF METABOLIC DISORDERS | 2019 |
|
RU2768171C2 |
| METHOD OF CORRECTING METABOLIC SYNDROME IN PATIENTS WITH DEFORMING OSTHEOARTHROSIS | 2007 |
|
RU2363460C1 |
| METHOD OF SELECTING MEN AT PRE-DIABETES RISK GROUP AND TYPE 2 DIABETES MELLITUS | 2017 |
|
RU2695322C2 |
